Clinical trials: Blepharokeratoconjunctivitis
Blepharokeratoconjunctivitis
Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects
The purpose of this study is to assess the safety and tolerability of ocular administration of Topical Interleukin-1-Receptor Antagonist in healthy volunteers.
- Trial name
- NCT03383276
- Testing
- IL-1Ra
- Where
- China
- Volunteers
- 34 people, healthy volunteers welcome
- Sponsor
- Beijing Tongren Hospital